SEC Company Response from Advanced BioPhotonics Inc. (CIK 0001096182) — Jul 1, 2005
Advanced BioPhotonics Inc. (CIK 0001096182)
Date: July 1, 2005 · CIK: 0001096182 · Accession: 0000911420-05-000272
AI Filing Summary & Sentiment
File numbers found in text: 333-122328
Letter
Re: Advanced BioPhotonics Inc.(formerly OmniCorder Technologies, Inc.) Registration Statement on Form SB-2 (No. 333-122328) ------------------------------------------------------------------
GREENBERG TRAURIG, LLP MetLife Building 200 Park Avenue, 15th Floor New York, New York 10166
Spencer G. Feldman 212-801-9221 E-mail: feldmans@gtlaw.com
June 30, 2005
VIA FAX AND EDGAR -----------------
U.S. Securities and Exchange Commission Judiciary Plaza 450 Fifth Street, N.W. Washington, D.C. 20549 Attention: Ms. Mary Beth Breslin Division of Corporation Finance
Ladies and Gentlemen:
On behalf of Advanced BioPhotonics Inc. (formerly OmniCorder Technologies, Inc.), we enclose Advanced BioPhotonics' request for acceleration of the above-referenced Registration Statement to 2:00 p.m., New York City time, on Friday, July 1, 2005, or as soon as possible thereafter, and acknowledgement of the statements contained in the Commission's letter to Advanced Biophotonics dated February 17, 2005.
Please advise the undersigned of the effectiveness of the Registration Statement.
Very truly yours,
/s/Spencer G. Feldman --------------------------------- Spencer G. Feldman
<PAGE>
ADVANCED BIOPHOTONICS INC. 125 Wilbur Place, Suite 120 Bohemia, New York 11716
June 30, 2005
U.S. Securities and Exchange Commission Judiciary Plaza 450 Fifth Street, N.W. Washington, D.C. 20549
Re: Advanced BioPhotonics Inc. (formerly OmniCorder Technologies, Inc.) Registration Statement on Form SB-2 (No. 333-122328) ----------------------------------------------------
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Advanced Biophotonics Inc. (formerly OmniCorder Technologies, Inc.) hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective at 2:00 p.m., New York City time, on Friday, July 1, 2005, or as soon as possible thereafter.
In connection with Advanced Biophotonics' request for acceleration of the effective date of the Registration Statement, Advanced Biophotonics acknowledges:
1. Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
2. The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve Advanced Biophotonics from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
3. Advanced Biophotonics may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
ADVANCED BIOPHOTONICS INC.
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
GREENBERG TRAURIG, LLP
MetLife Building
200 Park Avenue, 15th Floor
New York, New York 10166
Spencer G. Feldman
212-801-9221
E-mail: feldmans@gtlaw.com
June 30, 2005
VIA FAX AND EDGAR
-----------------
U.S. Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street, N.W.
Washington, D.C. 20549
Attention: Ms. Mary Beth Breslin
Division of Corporation Finance
Re: Advanced BioPhotonics Inc.(formerly OmniCorder Technologies, Inc.)
Registration Statement on Form SB-2 (No. 333-122328)
------------------------------------------------------------------
Ladies and Gentlemen:
On behalf of Advanced BioPhotonics Inc. (formerly OmniCorder
Technologies, Inc.), we enclose Advanced BioPhotonics' request for acceleration
of the above-referenced Registration Statement to 2:00 p.m., New York City time,
on Friday, July 1, 2005, or as soon as possible thereafter, and acknowledgement
of the statements contained in the Commission's letter to Advanced Biophotonics
dated February 17, 2005.
Please advise the undersigned of the effectiveness of the Registration
Statement.
Very truly yours,
/s/Spencer G. Feldman
---------------------------------
Spencer G. Feldman
<PAGE>
ADVANCED BIOPHOTONICS INC.
125 Wilbur Place, Suite 120
Bohemia, New York 11716
June 30, 2005
U.S. Securities and Exchange Commission
Judiciary Plaza 450 Fifth Street, N.W.
Washington, D.C. 20549
Re: Advanced BioPhotonics Inc. (formerly OmniCorder
Technologies, Inc.)
Registration Statement on Form SB-2 (No. 333-122328)
----------------------------------------------------
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as
amended, Advanced Biophotonics Inc. (formerly OmniCorder Technologies, Inc.)
hereby requests that the effectiveness of the above-referenced Registration
Statement be accelerated so that it will become effective at 2:00 p.m., New York
City time, on Friday, July 1, 2005, or as soon as possible thereafter.
In connection with Advanced Biophotonics' request for acceleration of
the effective date of the Registration Statement, Advanced Biophotonics
acknowledges:
1. Should the Commission or the staff, acting pursuant to
delegated authority, declare the filing effective, it does not
foreclose the Commission from taking any action with respect to
the filing;
2. The action of the Commission or the staff, acting pursuant to
delegated authority, in declaring the filing effective, does not
relieve Advanced Biophotonics from its full responsibility for
the adequacy and accuracy of the disclosure in the filing; and
3. Advanced Biophotonics may not assert staff comments and the
declaration of effectiveness as a defense in any proceeding
initiated by the Commission or any person under the federal
securities laws of the United States.
Very truly yours,
ADVANCED BIOPHOTONICS INC.
By: /s/ Denis A. O'Connor
---------------------------------------
Denis A. O'Connor
President and Chief Executive Officer
</TEXT>
</DOCUMENT>